BEAM

Latest SEC Filings & News for BEAM

1 most recent filing and news item mentioning BEAM. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/BEAM/news?limit=20"

Pull BEAM filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Beam Doses First Patient in BEAM-302 Global Pivotal Trial; Reports Q1

Beam Therapeutics dosed the first patient in the global pivotal cohort of its BEAM-302 trial for AATD and reported $1.2 billion in cash, indicating continued clinical progress and operational strength.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.